valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

Xylem Inc. (XYL) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$47.00 ComplexityAverage Updated
$44.00 $89.00
bear $44.00 base $73.00 bull $89.00 margin of safety $47.00 market price* $104.05
Xylem makes and services equipment that moves, treats, measures and tests water: pumps and treatment systems, smart meters and analytics for utilities, and applied water equipment for buildings and industry. It reports in four segments: Water Infrastructure, Applied Water, Measurement and Control Solutions, and Water Solutions and Services. About 58% of 2025 revenue came from the United States, 20% from Western Europe and 14% from emerging markets. No customer exceeded 5% of revenue. How we measured earnings. We start from operating cash flow, remove the swings from receivables, inventories, payables, accrued liabilities and taxes, subtract stock compensation as a real cost, and subtract only the capital spending needed to keep the business running rather than to expand it. On that basis owner earnings per share were about $2.37 to $2.93 from 2018 to 2020-2022 ($2.37 in 2020, $2.61 in 2022), then $3.28 in 2023, $4.05 in 2024 and $4.09 in 2025. The jump reflects the May 2023 purchase of Evoqua, which added earnings and roughly 60 million shares. Because earlier years describe a much smaller business, we measure the level from 2023 to 2025 only; the median is about $4.05 per share. Growth in 2025 was 1.1%. We left two larger cash outflows in 2025 in place rather than adjusting them away: a $146 million build in long-term receivables and $64 million of other asset and liability changes. Our reconciliation of net income, non-cash charges and working capital back to reported operating cash flow ties exactly. About $308 million of 2025 depreciation and amortization is amortization of acquired intangibles, mostly from Evoqua. This is a sunk cost of past deals, so it is not charged against earnings, but it is a wasting asset, so we do not assume the earnings level grows on the back of it. Xylem also recorded goodwill impairments of $148 million in 2019 and $58 million in 2020, which we treat as a risk in the bear case. Base case, about $73 per share. Owner earnings start at the $4.05 level, grow 1% in the first year (at or below the 1.1% just achieved) and 1% a year for ten years, then stay flat. What is credited: modest price realization, which management cites as a driver in 2025, and a backlog of $4,615 million at the end of 2025, of which more than 60% is expected to convert to revenue during 2026. First-half 2026 revenue was $4,461 million against $4,370 million a year earlier (+2.1%) and operating cash flow was $398 million against $338 million, so the level still holds. What is left out: share gains, new products, margin expansion and any benefit from the Idrica acquisition of December 2024, none of which is secured or yet proven in the results. Bear case, about $44 per share. Backlog fell 9% during 2025 (from $5,070 million to $4,615 million), and the company discloses continuing exposure to tariffs, duties and input costs. We assume owner earnings fall about 20% to roughly $3.25 per share, close to the 2023 level, stay there for ten years, and then erode 3% a year as acquired technology and customer relationships age. Leverage is not the issue here: total debt was $1,942 million at the end of 2025, including $500 million of 3.25% notes due 2026, against about $1.0 billion of annual owner earnings. Bull case, about $89 per share. Owner earnings grow 3.5% a year for ten years, then stay flat. That rests on strong price realization continuing and on the backlog being executed on schedule, in line with the roughly 2% revenue growth already delivered in the first half of 2026 plus pricing. It does not assume growth beyond what the business has done. What would make this wrong. If the 9% backlog decline is the start of a longer downturn in utility and industrial spending, owner earnings could fall below the bear level. Conversely, if the 2024-2025 earnings level was itself lifted by one-time gains in working capital that reverse, the base case would be too high. We could not reconcile the 2025 build in long-term receivables to a recurring pattern from the filing alone, and it is the main reason we did not lift the earnings level above $4.05. The margin-of-safety price is near $47 per share, reflecting a stable, but project-exposed and acquisition-heavy, business.
Fiscal yearOwner's earningsMethodology
2025 $4.09 ▼
OE = CFO - WC cash effect - SBC - maintenance capex. CFO=$1,241M; WC cash effect=$(123)M (receivables -55, inventories +23, payables -22, accrued liabilities -69, taxes 0); long-term receivables -146 and other assets/liabilities -64 left in CFO; SBC=$53M; capex=$331M, growth capex=$18.4M (revenue +$473M at 3.90%) so maintenance capex=$312.6M; OE=$998.4M; diluted shares=243.994M; OE/sh=$4.09. Reconciliation: NI 950 + non-cash 732 - restructuring/pension cash 108 - WC lines 333 = CFO 1,241, ties. Source: FY2025 10-K accession 0001524472-26-000012.
2024 $4.05 ▼
OE = CFO - WC cash effect - SBC - maintenance capex. CFO=$1,263M; WC cash effect=$(53)M; SBC=$56M; capex=$321M, growth capex=$46.7M (revenue +$1,198M at 3.90%) so maintenance capex=$274.3M; OE=$985.7M; diluted shares=243.521M; OE/sh=$4.05. Source: FY2025 10-K accession 0001524472-26-000012.
2023 $3.28 ▼
OE = CFO - WC cash effect - SBC - maintenance capex. CFO=$837M; WC cash effect=$(137)M; SBC=$60M; capex=$271M, growth capex=$71.8M (revenue +$1,842M at 3.90%) so maintenance capex=$199.2M; OE=$714.8M; diluted shares=218.180M (Evoqua acquired May 2023, partial-year share count); OE/sh=$3.28. Source: FY2025 10-K accession 0001524472-26-000012.
2022 $2.61 ▼
OE = CFO - WC cash effect - SBC - maintenance capex. CFO=$596M; WC cash effect=$(108)M; SBC=$37M; capex=$208M, growth capex=$12.8M (revenue +$327M at 3.90%) so maintenance capex=$195.3M; OE=$471.7M; diluted shares=180.979M; OE/sh=$2.61. Source: FY2022 10-K accession 0001524472-23-000009.
2021 $2.58 ▼
OE = CFO - WC cash effect - SBC - maintenance capex. CFO=$538M; WC cash effect=$(158)M; SBC=$33M; capex=$208M, growth capex=$12.4M (revenue +$319M at 3.90%) so maintenance capex=$195.6M; OE=$467.4M; diluted shares=181.526M; OE/sh=$2.58. Source: FY2022 10-K accession 0001524472-23-000009.
2020 $2.37 ▼
OE = CFO - WC cash effect - SBC - maintenance capex. CFO=$824M; WC cash effect=$+186M; SBC=$26M; capex=$183M, growth capex=$0 (revenue declined) so maintenance capex=$183M; OE=$429M; diluted shares=181.099M; OE/sh=$2.37. Source: FY2022 10-K accession 0001524472-23-000009.
2019 $2.93 ▼
OE = CFO - WC cash effect - SBC - maintenance capex. CFO=$839M; WC cash effect=$+55M; SBC=$29M; capex=$226M, growth capex=$1.6M (revenue +$42M at 3.90%) so maintenance capex=$224.4M; OE=$530.6M; diluted shares=181.196M; OE/sh=$2.93. Source: FY2019 10-K accession 0001524472-20-000006.
2018 $2.72 ▼
OE = CFO - WC cash effect - SBC - maintenance capex. CFO=$586M; WC cash effect (receivables, inventories, payables, accrued liabilities, accrued taxes)=$(155)M so removing it adds $155M; SBC=$30M; capex=$237M, capex/revenue ratio 3.90% (mean FY2017-25), growth capex=$19.5M on revenue +$500M so maintenance capex=$217.5M; OE=$493.5M; diluted shares=181.132M; OE/sh=$2.72. Long-term receivables and 'other assets and liabilities' lines left in CFO. Source: FY2019 10-K accession 0001524472-20-000006.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States (all regions, 58% of 2025 revenue); Western Europe (20%); emerging markets across Eastern Europe, the Middle East, Africa, Latin America and Asia Pacific excluding Japan, Australia and New Zealand (14%); other regions including Japan, Australia and New Zealand (8%)
Historical growth strategy

We don't have historical growth strategy information for this company yet.

Chart analysis

We don't have chart analysis for this company yet.

Competitors

We don't have competitor information for this company yet.

Circle of competence

We don't have circle of competence information for this company yet.